Diabetes Medications — Tracker, Interactions and AI Scanner

Diabetes medicines work best when you understand what each one does, take them consistently, and review them regularly with your clinician. Modern type 2 diabetes care draws on several drug classes that lower blood glucose in different ways, and many people take more than one. This page explains the major classes in plain language and introduces tools that help you track doses, scan a prescription, and flag possible interactions. It is educational and does not replace medical advice — every prescription decision is clinician-supervised.

The major diabetes drug classes

Each class lowers glucose through a distinct mechanism, and your clinician chooses based on your A1c, weight, heart and kidney health, cost, and side-effect profile. The ADA Standards of Care in Diabetes (2025) recommend individualising therapy rather than a one-size-fits-all ladder.

• Metformin (biguanide): usually the first-line oral medicine. It reduces glucose production by the liver and improves insulin sensitivity. Common side effects are digestive — nausea, loose stools — which often ease with the extended-release form or by taking it with food.
• Sulfonylureas (e.g. glimepiride, gliclazide): stimulate the pancreas to release more insulin. They are inexpensive and effective but carry a higher risk of low blood glucose (hypoglycaemia) and modest weight gain.
• DPP-4 inhibitors (e.g. sitagliptin, linagliptin): boost the body's own incretin hormones to raise insulin after meals. They are weight-neutral and generally well tolerated, with a lower hypoglycaemia risk on their own.
• SGLT2 inhibitors (e.g. empagliflozin, dapagliflozin): make the kidneys pass excess glucose in urine. Beyond glucose control they have shown heart and kidney benefits in large outcome trials. Watch for genital yeast infections, dehydration, and rare diabetic ketoacidosis.
• GLP-1 receptor agonists (e.g. semaglutide, dulaglutide, liraglutide): slow stomach emptying, curb appetite, and improve insulin release. They deliver strong A1c and weight reduction. Nausea is the most common early side effect. These are prescription only and clinician-supervised.
• Insulin: the most powerful glucose-lowering therapy, essential for all type 1 diabetes and for some type 2. It ranges from long-acting basal insulins to rapid mealtime insulins. The main risks are hypoglycaemia and weight gain, managed by careful dosing and monitoring.

Track every dose in one place

Consistency is the single biggest lever in medication effectiveness. The tracker lets you log each medicine, set reminders, and see adherence trends alongside your glucose data so you can discuss real patterns with your care team rather than relying on memory.

• Log oral tablets, injectables, and insulin units with time stamps.
• Set repeating reminders and mark doses taken or missed.
• View adherence next to glucose readings to spot cause and effect.

Prescription scanner

The AI prescription scanner reads a photo of your prescription or medicine label and helps you build your medication list without typing each name. It recognises common diabetes drugs and dosages and flags anything it cannot read clearly so you can confirm it. Always check the scanned result against the actual label — this is a convenience aid, not a pharmacist.

Interaction checks

When you add a medicine, the interaction checker highlights well-known combinations that deserve attention — for example, medicines that raise hypoglycaemia risk when combined, or those that interact with alcohol or imaging contrast dye. It is designed to prompt a conversation, never to block your care. Confirm any flag with your pharmacist or clinician before acting.

How your clinician chooses a medicine

There is no fixed ladder that every person climbs in the same order. Instead, the ADA Standards of Care in Diabetes (2025) ask clinicians to match the medicine to the person. Several factors shape the decision, and they often point toward a specific class rather than the cheapest or newest option.

• Your A1c and how far it is from target influences how strong a glucose-lowering effect you need.
• Heart and kidney health can move an SGLT2 inhibitor or GLP-1 agonist to the front of the line because of their proven organ-protective benefits.
• Weight goals may favour a GLP-1 agonist, which supports weight loss, over a sulfonylurea or insulin, which can add weight.
• Hypoglycaemia risk matters for people who drive for a living, live alone, or are older, steering away from drugs that cause frequent lows.
• Cost, access, and preference including whether you can manage an injection or prefer a tablet.

Because so much is individual, the same diagnosis can lead to very different prescriptions for two different people, and both can be correct.

Taking your medicines safely

Getting the most from any medicine comes down to a few habits that reduce side effects and keep glucose steady.

• Take doses at consistent times so levels stay stable; the tracker's reminders help here.
• Follow food instructions — metformin is gentler on the stomach with meals, while some medicines are timed around eating.
• Learn the signs of low blood glucose (shakiness, sweating, confusion) if you take insulin or a sulfonylurea, and know how to treat it.
• Store insulin correctly, keeping unopened supplies refrigerated and protecting pens from heat.
• Do not double up if you miss a dose without checking the guidance for that specific medicine.

Bring your full medication list to every appointment so your clinician can review whether each drug is still the right fit.

Injectable and oral options

Many people assume injections mean insulin, but several modern medicines are injected without being insulin. GLP-1 agonists are often weekly injections, and some now come as tablets. Insulin itself ranges from once-daily basal injections to mealtime doses. If needle anxiety is a barrier, tell your clinician — pen devices, fine needles, and oral alternatives can make treatment far easier to live with. The scanner and tracker handle both oral and injectable medicines so your whole regimen sits in one place.

Medicines and reversal are not either-or

For many people with type 2 diabetes, sustained lifestyle change can lower A1c enough that a clinician safely reduces or, in some cases, deprescribes medication — the state the ADA defines as remission (A1c under 6.5% for at least three months off glucose-lowering drugs). Trials such as DiRECT (Lancet, 2018, with two-year data in 2019) and Virta Health's two-year data (2019) showed that meaningful numbers of people can reduce or stop medicines under supervision, though results vary. Type 1 diabetes always requires insulin, and you should never stop or change a dose on your own. Any tapering happens with your clinician watching your numbers.

Frequently Asked Questions

Which diabetes medicine is best?

There is no single best drug. Metformin is the usual starting point, but SGLT2 inhibitors and GLP-1 agonists are often added or prioritised when heart or kidney protection or weight loss matters. Your clinician tailors the choice to you.

Can I stop my medication if my glucose is normal?

Only your clinician can decide that. Good numbers may mean your treatment is working, not that you no longer need it. Stopping abruptly can cause glucose to rebound. Discuss any reduction plan and monitor closely.

Is the scanner a substitute for a pharmacist?

No. The scanner speeds up building your list, but it can misread handwriting or unusual labels. Always verify against the printed label and ask a pharmacist if anything is unclear.

Do GLP-1 drugs and insulin need special supervision?

Yes. Both are prescription medicines that require dose titration and monitoring for side effects such as nausea or low blood glucose. They should only be used under clinician guidance.